Search

Reliance Pharma Fund Unrated

Value Research
0.77%
Change from previous, NAV as on Jul 29, 2016
Category: Equity: Pharma
Assets: R 1,463 crore (As on Jun 30, 2016)
Expense: 2.17% (As on Jun 30, 2016)
GET FUND UPDATES FROM VALUE RESEARCH IN YOUR INBOX
Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Managers
+ Sailesh Raj Bhan since Mar 2005
comments powered by Disqus